CN Patent

CN101220024A — 一组抑制激酶的抗癌化合物

Assigned to Individual · Expires 2008-07-16 · 18y expired

What this patent protects

本发明涉及一组抑制激酶的抗癌化合物，通过调控激酶活性治疗肿瘤及/或其他疾病。该组化合物结构如右式，本发明还涉及上述化合物药学上认可的盐，以及按照任何药物组合制备口服、注射、外用药物。

USPTO Abstract

本发明涉及一组抑制激酶的抗癌化合物，通过调控激酶活性治疗肿瘤及/或其他疾病。该组化合物结构如右式，本发明还涉及上述化合物药学上认可的盐，以及按照任何药物组合制备口服、注射、外用药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101220024A
Jurisdiction
CN
Classification
—
Expires
2008-07-16
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.